CD16/CD32 Monoclonal Antibody (93), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0451898
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $223.50
About this award
Life Technologies Corporation has been awarded contract A207_PO-0451898 by the University of Virginia, an institution located in Virginia. The award was executed on August 1, 2026, with a total contract value of $223. The prime contractor will deliver CD16/CD32 Monoclonal Antibody (93) manufactured by eBioscience to the University of Virginia as the buyer. The line item specifies a quantity of 223 units at a unit price of $1 per unit.
The deliverable under this contract constitutes a specialized immunological reagent commonly utilized in research and diagnostic laboratory applications. The CD16/CD32 Monoclonal Antibody serves as a binding agent for cluster of differentiation markers found on immune cells and is essential for flow cytometry, cell sorting, and immunological assay procedures. Performance of this contract is designated for delivery to the University of Virginia's facilities in Virginia, consistent with the institution's research and operational requirements.
Line items
| Item | Total |
|---|---|
| CD16/CD32 Monoclonal Antibody (93), eBioscience | $223.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0451898?
Contract A207_PO-0451898 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 1, 2026.
How much is contract A207_PO-0451898 worth?
Its cumulative value is $223.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award